Yaopharma Co., Ltd.

Telmisartan is a specific angiotensin II receptor (ATⅠ type) antagonist. Telmisartan replaces angiotensin II receptors and binds to ATⅠ receptor subtypes with high affinity. It has no agonist effect at any site, selectively binds to ATⅠ receptors, and the binding effect is long-lasting. Telmisartan has no affinity for other receptors. In humans, 80 mg of telmisartan can almost completely inhibit the increase in blood pressure caused by angiotensin II. The inhibitory effect lasts for 24 hours and can still be measured after 48 hours. The antihypertensive effect gradually becomes obvious within 3 hours after the first dose of telmisartan. The maximum antihypertensive effect can be obtained 4 weeks after the start of treatment and can be maintained in long-term treatment. If telmisartan treatment is suddenly interrupted, blood pressure will gradually return to the pre-treatment level after a few days without rebound hypertension. In a clinical trial study directly comparing two antihypertensive drugs, the incidence of dry cough in the telmisartan treatment group was significantly lower than that in the angiotensin converting enzyme inhibitor treatment group.

It can counteract the capillary dilation caused by allergic reactions, reduce capillary permeability, have a mild bronchial smooth muscle spasmolysis effect, and also have obvious central nervous system stabilization and certain antitussive effects.

It is an expectorant that increases the secretion of respiratory glands, dilutes sputum, and makes it easier to cough up.

It is a non-addictive antitussive drug with central and peripheral antitussive effects. It can slightly inhibit the bronchial receptors and weaken the cough reflex.

This product is a part of intravenous nutrition, used to supplement the daily physiological needs of various water-soluble vitamins so that the body's relevant biochemical reactions can proceed normally.

This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.

Unspecified